Yeastract
YEASTRACT+ INESC-ID IST IBB
Home > Go Back > View Contact/Credits     Tutorial     Help

 

Regulation Reference(s)

The Yeastract team, is actively curating each regulation evidence code, association type and environmental condition.
Transcription
Factor
Target
ORF/Genes
References Evidence
Code
Evidence
Experiment
Association
Type
Strain Environmental
Group
Environmental
Condition
Log2FC
Dal80p YDL210W PubMed external link Vissers S et al., European journal of biochemistry, 1989 May 1;181(2):357-61Vissers S et al., European journal of biochemistry, 1989 May 1;181(2):357-61 Indirect Enzyme activity - wt vs TF mutant Negative SIGMA1278b Nitrogen source quality/availability Medium + GABA N/A
PubMed external link Talibi D et al., Nucleic acids research, 1995 Feb 25;23(4):550-7Talibi D et al., Nucleic acids research, 1995 Feb 25;23(4):550-7 Indirect lacZ - wt vs TF mutant Negative S288c Nitrogen source quality/availability minimal proline medium (0,1% proline) N/A
PubMed external link AndrĂ© B et al., Nucleic acids research, 1995 Feb 25;23(4):558-64AndrĂ© B et al., Nucleic acids research, 1995 Feb 25;23(4):558-64 Indirect lacZ - wt vs TF mutant Negative S288c Nitrogen source quality/availability proline (0,1%) as the sole source of nitrogen (minimal medium) N/A
PubMed external link Cunningham TS et al., Journal of bacteriology, 1994 Aug;176(15):4718-25Cunningham TS et al., Journal of bacteriology, 1994 Aug;176(15):4718-25 Direct EMSA N/A S288c In vitro in vitro N/A
PubMed external link Cunningham TS et al., Journal of bacteriology, 1993 Sep;175(18):5851-61Cunningham TS et al., Journal of bacteriology, 1993 Sep;175(18):5851-61 Direct EMSA N/A S288c In vitro in vitro N/A
PubMed external link Coffman JA et al., Journal of bacteriology, 1997 Jun;179(11):3416-29Coffman JA et al., Journal of bacteriology, 1997 Jun;179(11):3416-29 Indirect lacZ - wt vs TF mutant Positive TCY1 Nitrogen source quality/availability Minimal medium + proline N/A
Indirect Northern blot - wt vs TF overexpression Positive TCY1 Nitrogen source quality/availability Minimal medium + proline N/A
PubMed external link Cox KH et al., Yeast (Chichester, England), 1999 Jun 15;15(8):703-13Cox KH et al., Yeast (Chichester, England), 1999 Jun 15;15(8):703-13 Indirect Microarray analysis - wt vs TF mutant Negative TCY1 Nitrogen source quality/availability Wickerham's minimal medium with 0,6% glucose and 0,1% of proline N/A
PubMed external link Garcia SC et al., FEMS microbiology letters, 2000 Mar 15;184(2):219-24Garcia SC et al., FEMS microbiology letters, 2000 Mar 15;184(2):219-24 Indirect lacZ - wt vs TF mutant Negative S288c Nitrogen source quality/availability Minimal proline medium 2 (MPM2 -in 1 l it contained 0.7 g MgSO4W7H2O, 1 g KH2PO4, 0.4 g CaCl2.2H20, 0.5 g NaCl, 1 g K2SO4, 10.5 g citric acidWH2O, 10 ml vitamin solution (250 mg D-biotin, 100 mg thiamineWHCl, 1 g myo-inositol, 200 mg calcium pantothenate and 100 mg pyridoxineWHCl per liter) and 1 ml of trace metal solution (10 mg H3BO3, 1 mg CuSO4W5H2O, 2 mg KI, 4 mg Na2MoO4W2H2O, 14 mg ZnSO4W7H2O N/A
PubMed external link Georis I et al., Molecular and cellular biology, 2009 Jul;29(13):3803-15Georis I et al., Molecular and cellular biology, 2009 Jul;29(13):3803-15 Indirect RT-PCR - wt vs TF mutant Negative S288c Nitrogen source quality/availability Exponential-phase cells cultivated in synthetic growth medium containing 0.1% proline as nitrogen source N/A
PubMed external link Deed NK et al., Applied microbiology and biotechnology, 2011 Mar;89(5):1537-49Deed NK et al., Applied microbiology and biotechnology, 2011 Mar;89(5):1537-49 Indirect Microarray analysis - wt vs TF mutant Negative S288c Complex industrial media wine fermentation exponential phase N/A
PubMed external link Cardillo SB et al., Microbiology (Reading, England), 2012 Apr;158(Pt 4):925-935Cardillo SB et al., Microbiology (Reading, England), 2012 Apr;158(Pt 4):925-935 Direct ChIP N/A S288c Nitrogen source quality/availability Minimal Media + GABA N/A
PubMed external link Levi CE et al., Biochemical and biophysical research communications, 2012 May 11;421(3):572-7Levi CE et al., Biochemical and biophysical research communications, 2012 May 11;421(3):572-7 Direct ChIP N/A S288c Carbon source quality/availability Exponential phase cells cultivated in minimal growth medium containing acetate and GABA N/A
PubMed external link Palavecino-Ruiz M et al., Microbiology (Reading, England), 2017 Nov;163(11):1692-1701Palavecino-Ruiz M et al., Microbiology (Reading, England), 2017 Nov;163(11):1692-1701 Indirect lacZ - wt vs TF mutant Negative 23344c Nitrogen source quality/availability Minimal medium containing a 0.17% Difco yeast nitrogen base (YNB without amino acids and ammonium sulphate), 2% glucose and 10mM proline. N/A
Indirect lacZ - wt vs TF mutant Negative 23344c Nitrogen source quality/availability Minimal medium (0.17% Difco yeast nitrogen base, 2% glucose and 10mM proline) after incubation with 0.1mM GABA during 1h . N/A
Indirect lacZ - wt vs TF mutant Negative 23344c Nitrogen source quality/availability wt and DELTAdal80 cells carrying the Yep-357-UGA4-lacZ plasmid were grown on 10mM proline and/or not incubated with 0.1mM GABA for 60 min N/A
Indirect lacZ - wt vs TF mutant Negative 23344c Nitrogen source quality/availability wt and DELTAgzf3DELTAdal80 cells carrying the Yep-357-UGA4-lacZ plasmid were grown on 10mM proline and/or not incubated with 0.1mM GABA for 60 min N/A
Indirect lacZ - wt vs TF mutant Negative 23344c Nitrogen source quality/availability wt and DELTAdal80DELTAleu3 cells carrying the Yep-357-UGA4-lacZ plasmid were grown on 10mM proline and/or not incubated with 0.1mM GABA for 60 min N/A
Indirect lacZ - wt vs TF mutant Negative 23344c Nitrogen source quality/availability wt and DELTAgzf3DELTAdal80DELTAleu3 cells carrying the Yep-357-UGA4-lacZ plasmid were grown on 10mM proline and/or not incubated with 0.1mM GABA for 60 min N/A
Indirect RT-PCR - wt vs TF mutant N/A 23344c Nitrogen source quality/availability Cells expressing HA-Dal80 were grown on proline without GABA vs incubated with 0.1 mM GABA for 30 min. ChIPs assays were carried out using antibodies against the HA epitope. N/A